Comment on “Understanding Atomoxetine Exposure Variability in Children and Adolescents with ADHD through Population Pharmacokinetics”

Journal of Clinical Pharmacology · Published 2026-05-29 · DOI 10.1002/jcph.70211

Authors (2)

Madhuri Tribhuvan, Shashikant N. Phatke

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Tribhuvan, M., Phatke, S. (2026). Comment on “Understanding Atomoxetine Exposure Variability in Children and Adolescents with ADHD through Population Pharmacokinetics”. Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70211

Related articles

• Understanding Atomoxetine Exposure Variability in Children and Adolescents With ADHD Through Population Pharmacokinetics · Journal of Clinical Pharmacology · 2026 · Cites or is cited by this article · Same journal
• A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants with End‐Stage Kidney Disease on Hemodialysis · Journal of Clinical Pharmacology · 2026 · Same journal
• A Phase 1 Oral Mass Balance and Combined Intravenous [ 14 C] Microtracer Study to Characterize the Absorption, Metabolism, Excretion, and Pharmacokinetics of Antitumor Drug E7386 in Humans · Journal of Clinical Pharmacology · 2026 · Same journal
• Population Pharmacokinetic Modeling of Intravenous Topiramate in Patients with Epilepsy or Migraine · Journal of Clinical Pharmacology · 2026 · Same journal
• Volumetric Absorptive Microsampling During Spaceflight for Analysis of Acetaminophen Pharmacokinetics in Whole Blood · Journal of Clinical Pharmacology · 2026 · Same journal
• Decoupling CAR‐T Expansion, Conversion, and Decay Timing: Physiologically Aligned Semi‐Mechanistic Modeling With Smooth Gating and a Cauchy Likelihood Residual Model · Journal of Clinical Pharmacology · 2026 · Same journal
• Hepatic CYP1A2 Activity in Adolescents with and without Obesity Assessed by the Urinary Paraxanthine‐to‐Caffeine Metabolic Ratio: A Pharmacokinetic Study · Journal of Clinical Pharmacology · 2026 · Same journal
• Pharmacokinetics, Safety, and Tolerability of Anti‐miR‐17 Oligonucleotide RGLS4326 in Healthy Adult Subjects · Journal of Clinical Pharmacology · 2026 · Same journal
• Population Pharmacokinetics and Exposure‐Safety Analysis of Furosemide in Preterm Infants · Journal of Clinical Pharmacology · 2026 · Same journal
• Population Pharmacokinetics of Oral Gecacitinib in Healthy Subjects and Patients with Autoimmune and Inflammatory Diseases · Journal of Clinical Pharmacology · 2026 · Same journal